PHASE III RANDOMIZED CONTROLLED TRIAL TO COMPARE BIOSIMILAR INFLIXIMAB (CT-P13) WITH INNOVATOR INFLIXIMAB IN PATIENTS WITH ACTIVE CROHN’S DISEASE: 1-YEAR MAINTENANCE AND SWITCHING RESULTS

Young-Ho Kim  1     Byong Duk Ye  2     Marina Pesegova  3     Olga Alexeeva  4     Marina Osipenko  5     Adi Lahat  6     Andriy Dorofeyev     Ágnes Szabone Salamon     Sigal Fishman     Olena Levchenko     Jae Hee Cheon     Maria Lia Scribano     Radu-Bogdan Mateescu     Kang Moon Lee     Chang Soo Eun     Sang Joon Lee     Sung Young Lee     Alex Kudrin    
1 Samsung Medical Center,Seoul,Korea, Republic of
2 Asan Medical Center,Seoul,Korea, Republic of
3 Krasnoyarsk Regional clinical hospital,Krasnoyarsk,Russian Federation
4 Nizhny Novgorod Regional Clinical Hospital,Nizhny Novgorod,Russian Federation
5 Novosibirsk State Medical University,Novosibirsk,Russian Federation
6 Sheba Medical Center,D

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing